Drug Approval | April 10, 2023
Virpax reports on progress of Envelta
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
Venkat Nageswar Chalasani has been appointed as an Independent Director of Apitoria Pharma with effect from April 4, 2023
Government hospitals like AIIMS, KGMC & many more as per day OPD patients are 18-25 thousand
The facility is over 79,000 square feet and is equipped with packaging lines
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
Pre-filled pens containing a combination of insulin glargine 100 Units/mL and lixisenatide for once-daily dosing
The agreement will facilitate the establishment of the IITK-UB Joint Center of Excellence in Biomedicine and Bioengineering
Women of all ages will get round-the-clock access to comprehensive treatment
Integration of modern and traditional medicine to facilitate the illness to wellness journey
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
Subscribe To Our Newsletter & Stay Updated
